Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07015125 · ClinicalTrials.gov registry record · NA
Evaluation of a Wearable Device for Acute Treatment of Migraines
A NA study, sponsored by Hinge Health.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07015125 is a NA study that has completed, run by Hinge Health. The registered enrollment target is 160 participants.
The verdict
NCT07015125, a NA study, has completed, sponsored by Hinge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine the efficacy of a new, improved neuromodulation device that can be worn on the head and neck to relieve migraine pain. To measure efficacy, investigators will compare how measured outcomes resulting from active stimulation with this device compare to those of sham treatment.
Interventions
- DEVICE Transcutaneous Electrical Nerve Stimulation (TENS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-06-09 |
| Est. Completion | 2025-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07015125
The ClinicalTrials.gov registry entry for NCT07015125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hinge Health, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Electrical Nerve Stimulation (TENS) is the first listed.
NCT07015125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07015125 about?
NCT07015125 is a clinical study titled "Evaluation of a Wearable Device for Acute Treatment of Migraines". The goal of this clinical trial is to determine the efficacy of a new, improved neuromodulation device that can be worn on the head and neck to relieve migraine pain. To measure efficacy, investigators will compare how measured outcomes resulting from active stimulation with this device compare to t...
What is the current status of trial NCT07015125?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2025-06-09. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT07015125?
The interventions under investigation include: Transcutaneous Electrical Nerve Stimulation (TENS) (DEVICE).
Who is sponsoring clinical trial NCT07015125?
This trial is sponsored by Hinge Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.